The list of effectors of Rab25 are increasing and while Rab11Fip1 or RCP was found to be a functional accomplice of Rab25 in luminal B cancers and is key for better stratification of luminal B patients, we are yet to understand the dynamics of Rab25-RCP in the other breast cancer subtypes. Here, RAB11FIP1 is linked to breast carcinoma.